Bromazepam
![]() | |
![]() | |
Clinical data | |
---|---|
Trade names | Lexotan, Lexotanil, others |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Addiction liability | High[1] |
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status |
|
P450 | |
Metabolites | 3-hydroxybromazepam |
Elimination half-life | 12–20 hours (avg. 17hr)[3] |
Excretion | Urine 69%, as metabolites[1] |
Identifiers | |
| |
JSmol) | |
SMILES
| |
| |
(verify) |
Bromazepam, sold under many brand names, is a benzodiazepine. It is mainly an anti-anxiety agent with similar side effects to diazepam. In addition to being used to treat anxiety or panic states, bromazepam may be used as a premedicant prior to minor surgery. Bromazepam typically comes in doses of 1.5 mg, 3 mg and 6 mg tablets.[4]
It was patented in 1961 by
Medical uses

Medical uses include treatment of severe anxiety.[6] Despite certain side effects and the emergence of alternative products (e.g. pregabalin), benzodiazepine medication remains an effective way of reducing problematic symptoms, and is typically deemed effective by patients[7][8] and medical professionals.[9][10][11] Similarly to other intermediate-acting
Pharmacology
Bromazepam is a "classical" benzodiazepine; other classical benzodiazepines include: diazepam, clonazepam, oxazepam, lorazepam, nitrazepam, flurazepam, and clorazepate.[16] Its molecular structure is composed of a diazepine connected to a benzene ring and a pyridine ring, the benzene ring having a single nitrogen atom that replaces one of the carbon atoms in the ring structure.[17] It is a 1,4-benzodiazepine, which means that the nitrogens on the seven-sided diazepine ring are in the 1 and 4 positions.
Bromazepam binds to the
After night time administration of bromazepam a highly significant reduction of gastric acid secretion occurs during sleep followed by a highly significant rebound in gastric acid production the following day.[22]
Bromazepam alters the electrical status of the brain causing an increase in beta activity and a decrease in alpha activity in EEG recordings.[23]
Pharmacokinetics
Bromazepam is reported to be metabolized by a hepatic enzyme belonging to the
The major metabolite of bromazepam is hydroxybromazepam,[24] which is an active agent too and has a half-life approximately equal to that of bromazepam.[citation needed]
Side-effects
Bromazepam is similar in side effects to other benzodiazepines. The most common side effects reported are drowsiness, sedation,
On occasion, benzodiazepines can induce extreme alterations in memory such as
Very rarely, dystonia can develop.[41]
Up to 30% treated on a long-term basis develop a form of dependence, i.e. these patients cannot stop the medication without experiencing physical and/or psychological
Ambulatory patients should be warned that bromazepam may impair the ability to drive vehicles and to operate machinery. The impairment is worsened by consumption of alcohol, because both act as central nervous system depressants. During the course of therapy, tolerance to the sedative effect usually develops.
Frequency and seriousness of adverse effects
As with all medication, the frequency and seriousness of side-effects varies greatly depending on quantities consumed.[42][43] In a study about bromazepam's negative effects on psychomotor skills and driving ability, it was noted that 3 mg doses caused minimal impairment.[44] It also appeared that impairment may be tied to methods of testing more so than on the product's intrinsic activity.[45]
Moreover, side-effects other than drowsiness, dizziness and ataxia seem to be rare[46] and not experienced by more than a few percent of users. The use of other, comparable medication seems to display an identically moderate side-effect profile.[47][48][49]
Tolerance, dependence and withdrawal
Prolonged use of bromazepam can cause tolerance and may lead to both physical and psychological dependence on the drug, and as a result, it is a medication which is controlled by international law. It is nonetheless important to note that dependence, long-term use and misuse occur in a minority of cases[50][51][52] and are not representative of most patients' experience with this type of medication.[53][54]
It shares with other benzodiazepines the risk of abuse, misuse,
Patients treated with bromazepam for generalised anxiety disorder were found to experience withdrawal symptoms such as a worsening of anxiety, as well as the development of physical withdrawal symptoms when abruptly withdrawn bromazepam.
Animal studies have shown that chronic administration of
Overdose
Bromazepam is commonly involved in drug overdoses.[65] A severe bromazepam benzodiazepine overdose may result in an alpha pattern coma type.[66] The toxicity of bromazepam in overdosage increases when combined with other CNS depressant drugs such as alcohol or sedative hypnotic drugs.[67] Similarly to other benzodiazepines however, being a positive modulator of certain neuroreceptors and not an agonist, the product has reduced overdose potential compared to older products of the barbiturate class. Its consumption alone is very seldom fatal in healthy adults.[68][69]
Bromazepam was in 2005 the most common benzodiazepine involved in intentional overdoses in France.[70] Bromazepam has also been responsible for accidental poisonings in companion animals. A review of benzodiazepine poisonings in cats and dogs from 1991 to 1994 found bromazepam to be responsible for significantly more poisonings than any other benzodiazepine.[71]
Contraindications
Benzodiazepines require special precaution if used in elderly, pregnant, child, alcohol- or drug-dependent individuals and individuals with
Special populations
- Globally, bromazepam is contraindicated and should be used with caution in women who are pregnant, the elderly, patients with a history of alcohol or other substance abuse disorders and children.
- In 1987, a team of scientists led by Ochs reported that the elimination half-life, peak serum concentration, and serum free fraction are significantly elevated and the oral clearance and volume of distribution significantly lowered in elderly subjects.[73] The clinical consequence is that the elderly should be treated with lower doses than younger patients.
- Bromazepam may affect driving and ability to operate machinery.[74]
- Bromazepam is
Interactions
Cimetidine, fluvoxamine and propranolol causes a marked increase in the elimination half-life of bromazepam leading to increased accumulation of bromazepam.[73][77][25]
Society and culture
Drug misuse
Bromazepam has a similar misuse risk as other benzodiazepines such as
Brand names
It is marketed under several brand names, including, Brozam, Lectopam, Lexomil, Lexotan, Lexilium, Lexaurin, Brazepam, Rekotnil, Bromaze, Somalium, Lexatin, Calmepam, Zepam and Lexotanil.[83]
Legal status
Bromazepam is a Schedule IV drug under the Convention on Psychotropic Substances.[84]
Synthesis

See also
References
- ^ a b "Bromazepam: Uses, Interactions, Mechanism of Action". DrugBank Online. Retrieved 2024-02-25.
- ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
- ^ "Lexotan (bromazepam) Product Insert" (PDF). Roche. 23 October 2012.
- ^ "Bromazepam". Pharmaceutical Benefits Scheme (PBS). Australian Government - Department of Health. Retrieved 23 March 2014.
- ISBN 9783527607495.
- ^ "Content Not Available". www.uptodate.com. Retrieved 2017-09-07.
- PMID 34934.
- PMID 6124936.
- PMID 2885173.
- PMID 6144455.
- ^ "Bromazépam" (PDF). Haute Autorité de santé (HAS) (in French). 7 September 2016.
- ^ "Bromazepam".
- ^ "Bromazépam". Répertoire des Spécialités Pharmaceutiques. ANSM: Agence Nationale de Sécurité du Médicament et des Produits de Santé (French: National Security Agency of Medicines and Health Products).
- PMID 6145073.
- PMID 2863089.
- PMID 639854.
- ^ Bromazepam Eutimia.com - Salud Mental. © 1999-2002.
- PMID 30204559.
- ^ Adeyemo MA, Idowu SO (25 November 2016). "Correlation of lipophilicity descriptors with pharmacokinetic parameters of selected benzodiazepines". African Journal of Biomedical Research. 19 (3): 213–218.
- PMID 2570451.
- PMID 6124947.
- PMID 4820635.
- S2CID 38155674.
- ^ S2CID 24131632.
- ^ S2CID 71812133.
- ^ "LECTOPAM®". RxMed. Retrieved 23 March 2014.
- PMID 8884760.
- PMID 16059590.
- S2CID 22491979.
- S2CID 36415883.
- PMID 2560.
- PMID 2577220.
- PMID 18094853.
- PMID 7178.
- PMID 2908134.
- PMID 9581.
- PMID 6124948.
- PMID 6124942.
- PMID 2862898.
- PMID 2876672.
- PMID 1292648.
- ^ "LEXOMIL - Bromazépam - Posologie, Effets secondaires, Grossesse".
- ^ "How to Manage Common Drug Side Effects".
- S2CID 25165191.
- S2CID 21899896.
- ^ "Side effect information for Bromazepam".
- ^ "Side effect information for Lorazepam".
- ^ "Side effect information for Diazepam".
- ^ "Notice patient - LORAZEPAM MYLAN 1 mg, comprimé pelliculé sécable - Base de données publique des médicaments".
- S2CID 5782780.
- S2CID 10441280.
- PMID 31088561.
- PMID 28614686.
- ^ HealthDay News (3 January 2019). "Prevalence of Benzodiazepine Use 12.6 Percent in the United States". Psychiatry Advisor. Haymarket.
- PMID 31644.
- PMID 37451.
- PMID 6145363.
- S2CID 32967696.
- PMID 6113557.
- S2CID 45915803.
- S2CID 260238907.
- PMID 18243.
- ^ Professor Heather Ashton (2002). "Benzodiazepines: How They Work and How to Withdraw".
- PMID 8105385.
- PMID 17173163.
- PMID 6140613.
- S2CID 19380042.
- S2CID 4675696.
- PMID 12712542.
- PMID 16097205.
- PMID 8588297.
- PMID 19900604.
- ^ S2CID 1099919.
- PMID 6118830.
- Hoffman LaRoche Pharmaceuticals (3 April 2008). "NAME OF THE MEDICINE LEXOTAN". Australia: roche-australia.com. Archived from the original(PDF) on 19 July 2008. Retrieved 16 December 2008.
- PMID 9422145.
- S2CID 22472247.
- PMID 6148695.
- S2CID 19379856.
- PMID 6519613.
- PMID 14506459.
- S2CID 23902799.
- ^ "Benzodiazepine Names". non-benzodiazepines.org.uk. Archived from the original on 2008-12-08. Retrieved 2008-10-31.
- ^ List of psychotropic substances under international control Archived December 5, 2005, at the Wayback Machine (PDF). International Narcotics Control Board.
- ^ Sanal (8 January 2012). "Synthesis Of Drugs: Laboratory Synthesis Of Bromazepam".
External links
- Bromazepam drug information from Lexi-Comp. Includes dosage information and a comprehensive list of international brand names.
- Inchem - Bromazepam